中文名称:倍他米松
- 16b-甲基-11b,17a,21-三羟基-9a-孕甾-1,4-二烯-3,20-二酮
- Betamethasone
- Betamethasone base; 9a-fluoro-11b,17a,21-trihydroxy-16b-methylpregna-1,4-diene-3,20-dione; 9alpha-fluoro-16beta-methylprednisolone; 9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; (11beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
- 378-44-9
- 206-825-4
- C22H29FO5
- 392.4611
- InChI=1/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
- 1.32g/cm3
- 235-237℃
- 568.2°C at 760 mmHg
- 297.5°C
- 2.81E-15mmHg at 25°C
- 色结晶性粉末。熔点231-234℃(分解)。无臭。醋酸倍他米松([987-24-6])亦为白色结晶性粉末,熔点205-208℃,微溶于丙醇、乙醇,极难溶于氯仿或乙醚,不溶于水,无臭。
- 激素类药。主要用于抗炎及抗过敏。适用于风湿性关节炎及各种皮肤病。倍他米松的作用同地塞米松,其抗炎作用比地塞米松、去炎松、氢化可的松强,副作用少。
- 醋酸倍他米松
- 醋酸倍他米松
化工网